218 related articles for article (PubMed ID: 17227781)
1. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.
Ripka S; König A; Buchholz M; Wagner M; Sipos B; Klöppel G; Downward J; Gress T; Michl P
Carcinogenesis; 2007 Jun; 28(6):1178-87. PubMed ID: 17227781
[TBL] [Abstract][Full Text] [Related]
2. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.
Aleksic T; Bechtel M; Krndija D; von Wichert G; Knobel B; Giehl K; Gress TM; Michl P
Oncogene; 2007 Aug; 26(40):5939-49. PubMed ID: 17369846
[TBL] [Abstract][Full Text] [Related]
3. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.
Michl P; Ramjaun AR; Pardo OE; Warne PH; Wagner M; Poulsom R; D'Arrigo C; Ryder K; Menke A; Gress T; Downward J
Cancer Cell; 2005 Jun; 7(6):521-32. PubMed ID: 15950902
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model.
Bo H; Gao L; Chen Y; Zhang J; Zhu M
Mol Med Rep; 2016 Feb; 13(2):1163-71. PubMed ID: 26648282
[TBL] [Abstract][Full Text] [Related]
5. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
Wei W; Li H; Li N; Sun H; Li Q; Shen X
Pancreatology; 2013; 13(4):384-92. PubMed ID: 23890137
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
7. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
[TBL] [Abstract][Full Text] [Related]
8. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
[TBL] [Abstract][Full Text] [Related]
9. CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
Wang J; Wang Y; Sun D; Ren F; Pang S; Xu S
Oncol Rep; 2017 May; 37(5):3068-3074. PubMed ID: 28405678
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
12. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
MacMillan CD; Leong HS; Dales DW; Robertson AE; Lewis JD; Chambers AF; Tuck AB
Sci Rep; 2014 Sep; 4():6315. PubMed ID: 25204426
[TBL] [Abstract][Full Text] [Related]
13. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer.
Nguyen HL; Kadam P; Helkin A; Cao K; Wu S; Samara GJ; Zhang Q; Zucker S; Cao J
Curr Cancer Drug Targets; 2016; 16(7):618-30. PubMed ID: 26881932
[TBL] [Abstract][Full Text] [Related]
14. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
15. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
Wei W; Sun HH; Li N; Li HY; Li X; Li Q; Shen XH
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):529-38. PubMed ID: 25308364
[TBL] [Abstract][Full Text] [Related]
16. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
17. CUTL1: a key mediator of TGFbeta-induced tumor invasion.
Michl P; Downward J
Cell Cycle; 2006 Jan; 5(2):132-4. PubMed ID: 16357536
[TBL] [Abstract][Full Text] [Related]
18. CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility.
Michl P; Knobel B; Downward J
J Biol Chem; 2006 Jun; 281(22):15138-44. PubMed ID: 16574653
[TBL] [Abstract][Full Text] [Related]
19. Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.
Ripka S; Riedel J; Neesse A; Griesmann H; Buchholz M; Ellenrieder V; Moeller F; Barth P; Gress TM; Michl P
Neoplasia; 2010 Aug; 12(8):659-67. PubMed ID: 20689760
[TBL] [Abstract][Full Text] [Related]
20. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]